A bacteriophage journey at the European Medicines Agency.

Laurent Debarbieux (1, 2) , Jean-Paul Pirnay (2) , Gilbert Verbeken (2) , Daniel de Vos (2) , Maia Merabishvili (2) , Isabelle Huys (2) , Olivier Patey (2) , Dirk Schoonjans (2) , Mario Vaneechoutte (2) , Martin Zizi (2) , Christine Rohde (3, 2)

1 BMGE - Biologie Moléculaire du Gène chez les Extrêmophiles
2 Queen Astrid Military Hospital [Brussels]
3 DSMZ - Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH / Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures

One sentence summary: The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology

Laurent Debarbieux, Jean-Paul Pirnay, Gilbert Verbeken, Daniel de Vos, Maia Merabishvili, et al.. A bacteriophage journey at the European Medicines Agency.. FEMS Microbiology Letters, 2016, 363 (2), pp.fnv225. ⟨10.1093/femsle/fnv225⟩. ⟨pasteur-01539082⟩